For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240521:nRSU3370Pa&default-theme=true
RNS Number : 3370P Assura PLC 21 May 2024
21 May 2024
Assura plc
("the Company")
Notifications of transactions by Persons Discharging Managerial
Responsibilities ("PDMRs")
The Company announces the following transactions in respect of Ordinary Shares
of 10 pence each in the Company ("Ordinary Shares"):
· Jonathan Murphy has acquired 198,975 Ordinary Shares at 43p
· Jayne Cottam has acquired 58,800 Ordinary Shares at 42.5p
Following the transactions, the total beneficial interest of Jonathan Murphy
and Jayne Cottam in the Ordinary Shares is 3,147,747 and 770,008 respectively.
The Notification of Dealing Forms can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jonathan Murphy
2 Reason for the notification
a) Position/status CEO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.43 GBP 198,975
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.43 GBP 198,975 £85,558.25 GBP
e) Date of the transaction 21 May 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.43 GBP 198,975 £85,558.25 GBP
e)
Date of the transaction
21 May 2024
f)
Place of the transaction
XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jayne Cottam
2 Reason for the notification
a) Position/status CFO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Assura plc
b) LEI 21380026T19N2Y52XF72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10 pence each
Identification code
GB00BVGBWW93
b) Nature of the transaction
Acquisition of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.425 GBP 58,800
d) Aggregated information
- Aggregated volume
Aggregate Price Aggregate Volume Aggregate Total
- Price
£0.425 GBP 58,800 £24,990 GBP
e) Date of the transaction 21 May 2024
f) Place of the transaction XLON
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price Aggregate Volume Aggregate Total
£0.425 GBP 58,800 £24,990 GBP
e)
Date of the transaction
21 May 2024
f)
Place of the transaction
XLON
For more information, please contact:
Assura plc Tel: 0161 515 2043
David Purcell, Investor Relations Director Email: Investor@assura.co.uk
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
Notes to Editors
Assura plc is the UK's leading specialist healthcare property investor and
developer. Assura enables better health outcomes through its portfolio of more
than 600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the
EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7
billion and has a strong track record of growing financial returns and
dividends for shareholders.
At Assura, we BUILD for health, having developed over 100 new healthcare
buildings in our history, and at the heart of our strategy sits The Bigger
Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available at www.assuraplc.com
(http://www.assuraplc.com)
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDUDBDDGSB